TrialArthritis research & therapy2006

Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study.

Serge D Steinfeld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.